NiKang Therapeutics has a total of 104 patents globally, out of which 8 have been granted. Of these 104 patents, more than 79% patents are active. The USA is where NiKang Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Taiwan. Parallelly, the USA seems to be the main focused R&D center of NiKang Therapeutics and is also the origin country of the firm.
NiKang Therapeutics was founded in the year 2017 by Yan Lou and Zhenhai Gao. The company is a biotech company focused on discovering and developing small molecule oncology medicines.
Do read about some of the most popular patents of NiKang Therapeutics which have been covered by us in this article and also you can find NiKang Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over NiKang Therapeutics patent portfolio.
How many patents does NiKang Therapeutics have?
NiKang Therapeutics has a total of 104 patents globally. These patents belong to 18 unique patent families. Out of 104 patents, 83 patents are active.
How Many Patents did NiKang Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant
NiKang Therapeutics Applications Filed
NiKang Therapeutics Patents Granted
2022
17
5
2021
35
2
2020
23
–
2019
27
–
2018
–
–
2017
–
–
How many NiKang Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did NiKang Therapeutics File in Different Countries?
Countries in which NiKang Therapeutics Filed Patents
Country
Patents
United States Of America
19
Europe
9
Taiwan
8
Canada
6
Australia
6
Hong Kong (S.A.R.)
5
China
4
Israel
4
Singapore
3
South Africa
2
Mexico
2
Brazil
2
India
2
Colombia
1
Costa Rica
1
Philippines
1
Indonesia
1
Chile
1
Where are Research Centres of NiKang Therapeutics Patents Located?
10 Best NiKang Therapeutics Patents
US20200115389A1 is the most popular patent in the NiKang Therapeutics portfolio. It has received 12 citations so far from companies like Relay Therapeutics and D. E. Shaw Research.Below is the list of 10 most cited patents of NiKang Therapeutics:
What are NiKang Therapeutics key innovation segments?
What Technologies are Covered by NiKang Therapeutics?
The chart below distributes patents filed by NiKang Therapeuticsin different countries on the basis of the technology protected in patents. It also represents the markets where NiKang Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has NiKang Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by NiKang Therapeutics?
Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be
Relmada Therapeutics has a total of 72 patents globally, out of which 25 have been granted. Of these 72 patents, more than 34% patents are active. The United States of America is where Relmada Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United
Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to
Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Countries in which NiKang Therapeutics Filed Patents
